Pure Global

Rapid test for detection of Antigens to Dengue NS1 and detection of Antibodies to Dengue IgG/IgM in Human Serum/Plasma/Whole Blood - India CDSCO Medical Device Registration

Rapid test for detection of Antigens to Dengue NS1 and detection of Antibodies to Dengue IgG/IgM in Human Serum/Plasma/Whole Blood is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000085_4bb80a2066d1f0efb97145c316109fab_3f1dcaf1423ad17a23303b64ded8f53c. This device is marketed under the brand name C Reactive Protein. The license holder is Voxtur Bio Ltd, and it is classified as Device Class Class C. The approving authority is Central Drug Standards Control Organization, West Zone.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Rapid test for detection of Antigens to Dengue NS1 and detection of Antibodies to Dengue IgG/IgM in Human Serum/Plasma/Whole Blood
UID: MFG/IVD/2022/000085_4bb80a2066d1f0efb97145c316109fab_3f1dcaf1423ad17a23303b64ded8f53c

Brand Name

C Reactive Protein

License Holder

Voxtur Bio Ltd

Device Class

Class C

Approving Authority

Central Drug Standards Control Organization, West Zone

Product Information

Rapid test for detection of Antigens to Dengue NS1 and detection of Antibodies to Dengue IgG/IgM in Human Serum/Plasma/Whole Blood

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing